Ignite Creation Date:
2025-12-24 @ 3:49 PM
Ignite Modification Date:
2026-01-13 @ 11:52 PM
Study NCT ID:
NCT00159692
Status:
COMPLETED
Last Update Posted:
2021-01-28
First Post:
2005-09-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Amlodipine Diabetic Hypertension Efficacy Response Trial
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hypertension | View |
Keywords: